Jaypee Brothers
In Current Chapter
In All Chapters
X
Clear
X
GO
Normal
Sepia
Dark
Default Style
Font Style 1
Font Style 2
Font Style 3
Less
Normal
More
Principles and Practices of Thyroid Gland Disorders
Subhash K Wangnoo, Jamal Ahmad, Mohammad A Siddiqui
CHAPTER 1:
Anatomical and Functional Embryology and Histology of Thyroid Gland
INTRODUCTION
DEVELOPMENT OF THE THYROID GLAND
DESCENT OF THE THYROID GLAND
THYROID EMBRYOLOGY: CLINICAL CORRELATIONS
ANATOMY AND HISTOLOGY
C Cells
Ultimobranchial Body-derived Epithelial Cells
CONCLUSION
CHAPTER 2:
Physiology of Thyroid Axis
INTRODUCTION
PHYLOGENY
ANATOMY AND EMBRYOLOGY
THYROID AXIS
Thyrotropin Releasing Hormone
Effects
Clinical Applications
Thyroid Stimulating Hormone
Biosynthesis
Thyroid Stimulating Hormone Secretion
Thyroid Hormones
Synthesis (Fig. 1)
Mechanism of Thyroid Action
Thyroid Hormone Metabolism
CONCLUSION
CHAPTER 3:
Laboratory Evaluation of Thyroid Functions: Dilemmas and Pitfalls
INTRODUCTION
HORMONAL TEST
Overview
Preanalytical Variations
Analytical Variations
OTHER TESTS
Calcitonin
Thyroglobulin
Immunological Test
CONCLUSION
Acknowledgments
CHAPTER 4:
Relevance of Thyroid Autoantibodies in Patients with Thyroid Dysfunction and in General Population
INTRODUCTION
PREVALENCE OF THYROID DYSFUNCTION AND THYROID AUTOANTIBODIES
HISTORICAL ASPECT
Hygiene Hypothesis
THYROID AUTOANTIBODIES
METHODS OF ESTIMATION
Thyroid Stimulating Hormone Receptor Antibodies15,18
Bioassay Methods
Receptor Method
Antithyroid Peroxidase Autoantibodies
Antithyroglobulin Antibodies13
PATHOGENESIS OF AUTOIMMUNE THYROID DISORDER
THYROID ANTIBODIES AND GRAVES’ DISEASE
THYROID ANTIBODIES AND AUTOIMMUNE THYROIDITIS
THYROID ANTIBODIES AND PREGNANCY
THYROID AUTOIMMUNITY AND IN VITRO FERTILIZATION
POSTPARTAL THYROIDITIS
THYROID ANTIBODIES IN GENERAL POPULATION
THYROID ANTIBODIES AND OTHER DISEASES
RELEVANCE OF THYROID ANTIBODIES: UNITED STATES PREVENTIVE SERVICES TASK FORCE GUIDELINES
CONCLUSION
CHAPTER 5:
Manifestations of Thyroid Hormone Deficiency and Laboratory Evaluation
INTRODUCTION
CLINICAL MANIFESTATIONS
Skin and Appendages
Hematologic
Cardiovascular System
Respiratory System
Gastrointestinal Disorders
Reproductive Abnormalities
Nervous System6
Muscular System
Skeletal System
Renal Function
Pituitary and Adrenal Function
Metabolic Abnormalities
CLINICAL MANIFESTATIONS IN INFANTS AND CHILDREN6
LABORATORY EVALUATION6
CONCLUSION
CHAPTER 6:
Hypothyroidism
INTRODUCTION
EPIDEMIOLOGY
CLINICAL FINDINGS
DIAGNOSIS
Primary Hypothyroidism
Secondary and Tertiary (Central) Hypothyroidism
EVALUATION
SCREENING
Indications for Screening
Screening Tests
Recommendations by Expert Groups
RECOMMENDATIONS
TREATMENT
Replacement with Thyroxine
Initiation of Therapy
Monitoring Thyroxine Therapy
Clinical Response
Treatment Failures
Conditions Associated with Altered Thyroxine Requirement
Central Hypothyroidism
Pregnancy
Ischemic Heart Disease
Myxedema Coma
Adverse Effects of Thyroxine Therapy
CONCLUSION
CHAPTER 7:
Hypothyroidism and Pregnancy
INTRODUCTION
EPIDEMIOLOGY
PATHOPHYSIOLOGY OF THYROID DURING PREGNANCY
OBSTETRICAL COMPLICATIONS OF MATERNAL HYPOTHYROIDISM
NEONATAL AND LONG-TERM COMPLICATIONS OF MATERNAL HYPOTHYROIDISM
SCREENING FOR HYPOTHYROIDISM
MANAGEMENT
Guidelines for Treatment of Hypothyroidism during Pregnancy
Management of Subclinical Hypothyroidism
Monitoring
CONCLUSION
CHAPTER 8:
Congenital Hypothyroidism
INTRODUCTION
EPIDEMIOLOGY
FETAL THYROID DEVELOPMENT AND FUNCTION
NEONATAL THYROID FUNCTION
THYROID FUNCTION IN PRETERM INFANTS
CLASSIFICATION OF CONGENITAL HYPOTHYROIDISM
ETIOLOGY OF CONGENITAL HYPOTHYROIDISM
Primary Congenital Hypothyroidism
Central Hypothyroidism
Transient Congenital Hypothyroidism
CLINICAL PRESENTATION
SCREENING FOR CONGENITAL HYPOTHYROIDISM
Screening Strategies
Ideal Time for Screening
Rescreening
Method of Screening
Interpretation of Results
Evaluation of Abnormal Screening Results
Low Thyroxine and Increased Thyroid Stimulating Hormone
Low Thyroxine and Normal Thyroid Stimulating Hormone
DIAGNOSTIC EVALUATION
TREATMENT
INTELLECTUAL OUTCOME
LEVOTHYROXINE THERAPY AND CARDIOVASCULAR EFFECTS IN LONG TERM
CONCLUSION
CHAPTER 9:
Subclinical Hypothyroidism
INTRODUCTION
WHEN TO EVALUATE FOR SUBCLINICAL HYPOTHYROIDISM?
DECISION MAKING IN TREATMENT: EVIDENCE
Symptoms of Hypothyroidism
Goiter and Thyroid Cancer
Dyslipidemia
Adverse Cardiac Endpoints
Causes of Subclinical Hypothyroidism (Box 1)
Thyroid Antibody Testing
Imaging and Additional Testing Modalities
Whom to Treat?
How to Treat?
CONCLUSION
CHAPTER 10:
Hashimoto's Thyroiditis
INTRODUCTION
EPIDEMIOLOGY
PATHOPHYSIOLOGY
Autoreactive T-cells
Autoantibodies in Hashimoto's Thyroiditis
Atrophic Hashimoto's Thyroiditis
HISTOPATHOLOGY
RISK FACTORS
Genetic Risk Factors
Human Leukocyte Antigens Associated Factors
Non-human Leukocyte Antigen Associated Factors
Nongenetic Risk Factors
Postpartum Period
Iodine Toxicity
Smoking
Selenium Deficiency
Endocrine Disruptors of Thyroid
Cytokine Therapy
Anticancer Therapy
Irradiation
ASSOCIATION OF HASHIMOTO'S THYROIDITIS WITH OTHER AUTOIMMUNE DISEASES
CLINICAL PRESENTATION
Rapid Enlargement of Thyroid Gland
Hashitoxicosis
Onset and Progression of Hypothyroidism
Spontaneous Reversion to Euthyroid State
Painful Goiter
Unusual Syndromes Associated with Hashimoto's Thyroiditis
Association of Thyroid Cancer with Hashimoto's Thyroiditis
Remission of Hashimoto's Thyroiditis
Effect of Hashimoto's Thyroiditis in Mother on Fetus
Hashimoto's Ophthalmopathy
DIAGNOSIS
Clinical
Biochemical
Pathological
Radionuclide Tests
Ultrasound
DIFFERENTIAL DIAGNOSIS
THERAPY
Thyroid Hormone Therapy
Glucocorticoids
Selenium
Surgery
CONCLUSION
CHAPTER 11:
Optimal Thyroid Replacement in Hypothyroidism
INTRODUCTION
PHARMACOLOGY OF THYROID HORMONE PREPARATION
Thyroid Extract
Levothyroxine Preparation
Liothyronine Preparation
Combination of Triiodothyronine and Thyroxine
THERAPEUTIC APPROACH TO HYPOTHYROIDISM
Choice of Preparation
Initiation of Therapy
THYROID HORMONE REPLACEMENT IN SPECIAL SITUATIONS
Elderly
Underlying Cardiac Disease
Central Hypothyroidism
Neonates
Pregnancy
Subclinical Hypothyroidism
MONITORING THYROXINE THERAPY
RESPONSE TO THYROXINE TREATMENT
CONDITIONS WITH ALTERED THYROXINE REQUIREMENT2
Reduced Requirements
Increased Requirements
Increased Clearance
Reduced Thyroxine to Triiodothyronine Conversion
Unknown Mechanism
ADVERSE EFFECTS OF THYROXINE THRAPY
TREATMENT FAILURE
Persistent High Thyroid Stimulating Hormone Concentrations
Hypothyroid Symptoms Despite Normal Thyroid Functions
CONCLUSION
CHAPTER 12:
Graves’ Disease
INTRODUCTION
EPIDEMIOLOGY
PATHOPHYSIOLOGY
CLINICAL FEATURES OF GRAVES’ DISEASE
Cutaneous Manifestations
Infiltrative Dermopathy
Ocular Manifestation
Cardiovascular System
Neurological and Neuropsychiatry Manifestations
Gastrointestinal Findings
Skeleton and Calcium Metabolism
Reproductive System
Thymus
Elderly Individuals
DIAGNOSIS OF GRAVES’ DISEASE
Laboratory Measurement
Radioiodine Uptake and Isotope Scan
Antibodies and Tests of Autoimmunity
Ultrasound of Thyroid
TREATMENT OF GRAVES’ DISEASE
Symptomatic Control
Thionamides
Pharmacology of Thionamides
Choice of Thionamides
Dosing and Regimen of Thionamides
Side Effects of Thionamides
Monitoring and Duration of Therapy
Radioiodine Treatment for Graves’ Disease
Thyroidectomy
Adjunctive Therapies
Choice of Therapy in Graves’ Disease
Treatment of Graves’ Ophthalmopathy
Treatment of Thyroid Dermopathy and Acropachy
CONCLUSION
CHAPTER 13:
Radioiodine Ablation in Graves’ Disease
INTRODUCTION
MECHANISM OF ACTION OF RADIOIODINE
INDICATIONS OF RADIOIODINE THERAPY
PRETREATMENT WITH ANTITHYROID DRUGS
Calculation of Dose
Monitoring and Follow up
OPHTHALMOPATHY AND RADIOIODINE THERAPY
Radioiodine Therapy in Pediatric Graves’ Disease
Radioiodine Therapy in Reproductive Women
Adverse Effects
Carcinogenicity and Teratogenicity
CONCLUSIONS
CHAPTER 14:
Hyperthyroidism in Pregnancy
INTRODUCTION
EPIDEMIOLOGY AND DIFFERENTIAL DIAGNOSIS
MANAGEMENT OF THYROTOXICOSIS DURING PREGNANCY
Associated Risk Assessment
Preconception Counseling
Management of Gestational Thyrotoxicosis
Management of Graves’ disease
Antithyroid Drugs
Beta-adrenergic Blocking Agents
Iodides
Surgery
Radioactive Iodine Therapy
Postpartum Thyroid Disease
CONCLUSION
CHAPTER 15:
Neonatal Thyrotoxicosis
INTRODUCTION
PHYSIOLOGY
ETIOLOGY
POINTERS TO DIAGNOSIS
COURSE
MANAGEMENT
Peripartal Management
Postnatal Management
PROGNOSIS
CONCLUSION
CHAPTER 16:
Pediatric Graves’ Disease
INTRODUCTION AND EPIDEMIOLOGY
ETIOLOGY AND PATHOGENESIS
CLINICAL PRESENTATION
LABORATORY FINDINGS
DIFFERENTIAL DIAGNOSIS
TREATMENT
Antithyroid Drugs (Box 3)
Propylthiouracil
Methimazole
Duration of Therapy
Radioactive Iodine
Surgery
CONCLUSION
CHAPTER 17:
Juvenile Thyrotoxicosis
INTRODUCTION
ETIOLOGY
CLINICAL FEATURES
Thyroid Associated Ophthalmopathy
INVESTIGATIONS
Thyroid Function Tests
Radioisotope Uptake Scan of the Thyroid Gland (Iodine-123 or Technetium-99m)
Ultrasonography with Color Doppler
Thyroid Antibodies
MANAGEMENT (TABLE 2)
What is New in the Treatment of Juvenile Thyrotoxicosis?
Symptomatic Treatment
Antithyroid Drugs
Thionamides
Side Effects of Antithyroid Drugs
Alternative Medical Management
Thyrotoxic Crisis
Management22
Disease Course and Remission with Medical Management
Definitive Therapy
Surgery
Radioiodine Ablation29
CONCLUSION
CHAPTER 18:
Thyrotoxicosis without Hyperthyroidism
INTRODUCTION
ETIOLOGY
Thyroiditis Group
Sporadic Painless Thyroiditis
Subacute Thyroiditis
Acute Infectious Thyroiditis
Hashitoxicosis
Nonthyroiditis Group
Exogenous Thyroid Hormone Intake
Thyrotoxicosis due to Metastatic Thyroid Carcinoma
Struma Ovarii
CONCLUSION
CHAPTER 19:
Subacute Thyroiditis
INTRODUCTION
CASE PRESENTATION
BACKGROUND
TYPES OF SUBACUTE THYROIDITIS
EPIDEMIOLOGY
NATURAL HISTORY OF THE DISEASE
Phase of Thyrotoxicosis
Phase of Hypothyroidism
Euthyroid Phase
PATHOPHYSIOLOGY
CLINICAL FEATURES
SUBACUTE GRANULOMATOUS OR DE QUERVAIN'S THYROIDITIS
Laboratory Findings
Imaging Findings
Differential Diagnosis
Treatment
Outcome and Prognosis
SILENT, PAINLESS, OR SUBACUTE LYMPHOCYTIC THYROIDITIS
Laboratory Findings
Imaging Findings
Differential Diagnosis
Treatment
Outcome and Prognosis
CONCLUSION
CHAPTER 20:
Toxic Nodular Goiter and Adenoma
INTRODUCTION
TOXIC NODULAR GOITER
Epidemiology
Pathogenesis
Histopathology
Clinical Features
Examination
Differential Diagnosis
Evaluation
BLOOD INVESTIGATIONS
IMAGING STUDIES
Invasive Tests
Treatment
Medical Treatment
Antithyroid Medications
Radioactive Iodine Treatment
Surgical Therapy
Summary of Treatment23
INDIAN PERSPECTIVE
TOXIC ADENOMA
Definition
Epidemiology
Pathogenesis
Clinical Presentation
TREATMENT
MALIGNANCY IN TOXIC ADENOMA OR MULTINODULAR GOITER
CONCLUSION
CHAPTER 21:
Simple or Nontoxic Goiter: Diffuse and Multinodular—Pathogenesis, Evaluation, and Management
INTRODUCTION
HISTORY
EPIDEMIOLOGY
NATURAL HISTORY
ETIOLOGY
Primary Factors
Secondary Factors
Iodine
Other Goitrogens
Sex Hormones
Other Growth Factors
CLINICAL FEATURES
EVALUATION
History and Examination
Investigations
Thyroid Function Tests
Thyroid Antibodies
Calcitonin and Thyroglobulin
Diagnostic Imaging
Ultrasound of the Neck
Thyroid Elastography
Computed Tomography and Magnetic Resonance Imaging
Thyroid Scintigraphy
Positron Emission Tomography
X-rays
Other Techniques
Fine Needle Aspiration Cytology
Pulmonary Function Tests
MANAGEMENT
Expectant Care
Levothyroxine Therapy
Iodine Supplementation
Surgery
Radioiodine Therapy
Recombinant Human Thyroid Stimulating Hormone
Percutaneous Interventional Therapy
CONCLUSION
CHAPTER 22:
Approach to the Solitary Thyroid Nodule
INTRODUCTION
PATHOPHYSIOLOGY
CLINICAL APPROACH TO THYROID NODULES
Thyroid Stimulating Hormone
Imaging
Ultrasound
Radionuclide Imaging
Fine Needle Aspiration Cytology
Cytology
MANAGEMENT
Nondiagnostic Cytology
Benign Cytology
Indeterminate Cytology
Atypia of Undetermined Significance/ Follicular Lesion of Undetermined Significance
Follicular Neoplasm
Suspicious for Malignancy
Malignant Cytology
CONCLUSION
CHAPTER 23:
Differentiated Thyroid Carcinoma
INTRODUCTION
HOW COMMON ARE THYROID CANCERS?
SHOULD WE SCREEN FOR THYROID CANCERS?
INSIGHTS INTO THE PATHOGENESIS OF DIFFERENTIATED THYROID CARCINOMAS
Oncogenes and Differentiated Carcinomas
Thyroid Irradiation
Iodine Intake
PATHOLOGICAL FEATURES OF THYROID MALIGNANCY
Papillary Carcinoma
Follicular Carcinoma
HOW DO THYROID CANCERS PRESENT?
ROLE OF IMAGING IN EVALUATION OF SUSPICIOUS LESIONS
ROLE OF FINE NEEDLE ASPIRATION CYTOLOGY
IMPORTANT FACTORS PREDICTING THE OUTCOME, STAGING, AND RISK STRATIFICATION OF DIFFERENTIATED THYROID CARCINOMAS
Staging Systems and Risk of Recurrence
Risk of Recurrence Based on Staging and Histology
OVERVIEW OF THE THERAPY FOR DIFFERENTIATED CANCERS
Surgery for the Thyroid Gland
Surgery of the Lymph Nodes
Radioactive Iodine Remnant Ablation and Therapy for Differentiated Thyroid Carcinomas
External Radiotherapy
LONG-TERM FOLLOW-UP OF PATIENTS WITH TREATED DIFFERENTIATED THYROID CANCERS
Levothyroxine Therapy
Clinical Examinations
Serum Thyroglobulin Measurements
Targeted Therapies for Differentiated Thyroid Cancers
CONCLUSION
CHAPTER 24:
Medullary Thyroid Cancer
INTRODUCTION
GENETICS
CLINICAL PRESENTATION
MANAGEMENT OF MEDULLARY CARCINOMA
Initial Evaluation
Surgical Management of Medullary Thyroid Carcinoma
Postoperative Management
MANAGEMENT OF PATIENTS WITH REGIONAL AND DISTANT METASTASIS
Systemic Therapy
CONCLUSION
CHAPTER 25:
Drugs Affecting Thyroid Function
INTRODUCTION
TYROSINE KINASE INHIBITORS AND THYROID FUNCTION
Sunitinib
Sorafenib
Vandetanib
Motesanib
Cabozantinib
Pazopanib
Nilotinib
Imatinib
Axitinib
Dasatinib
IMMUNE MODULATORS AFFECTING THYROID FUNCTION
Alemtuzumab and Graves’ Disease
Interferons and Other Cytokines
Lithium
DRUGS AFFECTING THYROID HORMONE REPLACEMENT THERAPY
Drugs Affecting Thyroid Hormone Absorption
Drugs Altering Thyroid Hormone Metabolism
Estradiol
CONCLUSION
CHAPTER 26:
Amiodarone-induced Thyroid Dysfunction
INTRODUCTION
EFFECT OF AMIODARONE ON EUTHYROID PATIENTS
How to Differentiate Between Type 1 and Type 2 Amiodarone-induced Thyrotoxicosis?
Differentiators between Amiodarone- induced Thyrotoxicosis Type 1 and Type 2
What Investigations Might Help?
TREATMENT
CONCLUSION
CHAPTER 27:
Resistance to Thyroid Hormones
INTRODUCTION
RESISTANCE TO THYROID HORMONE
CLINICAL FEATURES
LABORATORY DIAGNOSIS
TREATMENT
THYROID STIMULATING HORMONE RESISTANCE
CONCLUSION
CHAPTER 28:
Radioiodine in the Management of Benign Thyroid Disease
INTRODUCTION
PRINCIPLE OF RADIOIODINE THERAPY IN THYROID DISORDERS
SPECIFIC INDICATIONS OF RADIOIODINE THERAPY IN BENIGN THYROID DISORDERS
Graves’ Disease
Toxic Nodular Goiter
Toxic Adenoma
Euthyroid Goiter
Subclinical Hyperthyroidism
FACTORS INFLUENCING USE OF RADIOIODINE TREATMENT
ANTITHYROID DRUG ADMINISTRATION
CONTRAINDICATIONS TO RADIOIODINE THERAPY
ADMINISTRATION OF RADIOIODINE
FOLLOW-UP AFTER RADIOIODINE THERAPY
CONCLUSION
CHAPTER 29:
Thyroid Emergencies
INTRODUCTION
THYROID STORM
PATHOPHYSIOLOGY
ETIOLOGY
CLINICAL FEATURES
MANAGEMENT
Acute Intervention
Specific Treatment
Thyrostatics
Therapy Directed at Systemic Decompensation
NEWER THERAPIES
PROGNOSIS
Hypothyroid Coma (Myxedema Coma)
ETIOLOGY AND PRECIPITATING FACTORS
PATHOGENESIS
CLINICAL FEATURES
LABORATORY PARAMETERS
TREATMENT
General Supportive Treatment
Thyroid Hormone Replacement
HASHIMOTO'S ENCEPHALOPATHY
CONCLUSION
CHAPTER 30:
Endocrine Disruptors and Thyroid Disease
INTRODUCTION
ENDOCRINE DISRUPTORS
SOURCES OF EXPOSURE AND FACTORS AFFECTING IT
ENDOCRINE-DISRUPTING CHEMICALS AND ENDOCRINE SYSTEM
THYROID DISEASE
EFFECTS OF ENDOCRINE- DISRUPTING CHEMICALS ON SPECIFIC STAGES OF THYROID SYNTHESIS AND METABOLISM
Iodine Uptake in Thyroid Gland
Synthesis of Thyroid Hormones
Transport of Thyroid Hormones
Binding and Action of Thyroid Hormones
EFFECTS OF THYROID ON FETAL DEVELOPMENT
CARDIOVASCULAR RISK WITH THYROID DYSFUNCTION
THYROID AUTOIMMUNE DISEASE
CONCLUSION
CHAPTER 31:
Sick Euthyroid Syndrome
INTRODUCTION
DEFINITION
PATHOPHYSIOLOGY
PHYSIOLOGIC INTERPRETATION OF SICK EUTHYROID SYNDROME
DIAGNOSIS
THERAPY
PROGNOSTIC IMPLICATIONS
CONCLUSION
INDEX
TOC
Index
×
Chapter Notes
Save
Clear